Document is current
Any future updates will be listed below
-
Authors
Tovo-Rodrigues, Luciana http://orcid.org/0000-0002-8732-6059
Camerini, Laísa
Martins-Silva, Thais http://orcid.org/0000-0001-5049-2435
Carpena, Marina Xavier http://orcid.org/0000-0002-4690-5791
Bonilla, Carolina http://orcid.org/0000-0002-9972-6383
Oliveira, Isabel Oliveira http://orcid.org/0000-0002-0068-0806
de Paula, Cristiane Silvestre
Murray, Joseph
Barros, Aluísio J. D.
Santos, Iná S.
Rohde, Luis Augusto
Hutz, Mara Helena
Genro, Julia Pasqualini http://orcid.org/0000-0001-8394-1559
Matijasevich, Alicia
- License Information
-
More Information
Article History
Received: 27 July 2023
Revised: 29 April 2024
Accepted: 1 May 2024
First Online: 14 May 2024
Competing interests
: LAR has received grant or research support from, served as a consultant to, and served on the speakers’ bureau of Abdi-Ibrahim, Abbott, Aché, Adium, Aspen, Bial, Medice, Novartis/Sandoz, Pfizer/Upjohn, and Shire/Takeda in the last three years. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by LAR have received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Novartis/Sandoz and Shire/Takeda. LAR has received authorship royalties from Oxford Press and ArtMed. The other authors declare that they have no conflict of interest.
